Alnylam Says It's Not A 'Patent Troll' In Vax IP Row

Alnylam Pharmaceuticals has shot back at Moderna's request for about $2.8 million in legal costs it incurred defending a patent suit over its coronavirus vaccine, saying Moderna is wrongly trying to...

Already a subscriber? Click here to view full article